Shareholders might have noticed that Iochpe-Maxion S.A. (BVMF:MYPK3) filed its quarterly result this time last week. The early response was not positive, with shares down 3.6% to R$9.36 in the past week. Results were roughly in line with estimates, with revenues of R$4.0b and statutory earnings per share of R$0.58. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, the current consensus from Iochpe-Maxion's eight analysts is for revenues of R$15.7b in 2026. This would reflect a reasonable 3.9% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to surge 177% to R$1.69. Yet prior to the latest earnings, the analysts had been anticipated revenues of R$15.7b and earnings per share (EPS) of R$1.68 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
Check out our latest analysis for Iochpe-Maxion
It will come as no surprise then, to learn that the consensus price target is largely unchanged at R$12.95. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Iochpe-Maxion at R$16.00 per share, while the most bearish prices it at R$11.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Iochpe-Maxion's growth to accelerate, with the forecast 7.9% annualised growth to the end of 2026 ranking favourably alongside historical growth of 1.9% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 5.2% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Iochpe-Maxion to grow faster than the wider industry.
The Bottom Line
The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at R$12.95, with the latest estimates not enough to have an impact on their price targets.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Iochpe-Maxion analysts - going out to 2028, and you can see them free on our platform here.
Before you take the next step you should know about the 3 warning signs for Iochpe-Maxion (1 is a bit concerning!) that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.